Buprenorphine transdermal skin patch and Ranibizumab
Determining the interaction of Buprenorphine transdermal skin patch and Ranibizumab and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: buprenorphine
Brand name: Probuphine, Belbuca, Buprenex, Butrans, Sublocade, Subutex
Synonyms: Buprenorphine (implant), Buprenorphine
Generic Name: ranibizumab ophthalmic
Brand name: Lucentis
Synonyms: Ranibizumab (ophthalmic)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Buprenorphine transdermal skin patch-Ranibizumab Intraocular
- Buprenorphine transdermal skin patch-Ranibizumab ophthalmic
- Buprenorphine transdermal skin patch-Ranitidine
- Buprenorphine transdermal skin patch-Ranitidine Capsule
- Buprenorphine transdermal skin patch-Ranitidine Hydrochloride
- Buprenorphine transdermal skin patch-Ranitidine Injection
- Ranibizumab-Buprenorphine, Buprenorphine Hydrochloride
- Ranibizumab-Buprenorphine/naloxone Oromucosal, Sublingual
- Ranibizumab-Buproban
- Ranibizumab-Bupropion
- Ranibizumab-Bupropion and naltrexone
- Ranibizumab-Bupropion Extended-Release Tablets